Alumni Ventures Group, LLC is a venture capital firm based in Manchester, New Hampshire, founded in 2013. The firm specializes in seed and early-stage investments, as well as late-stage pre-IPO opportunities, with a flexible approach that is sector and geographic agnostic. Alumni Ventures aims to provide high-quality, diversified venture portfolios to individual investors, particularly accredited alumni from top entrepreneurial schools, who may not have had access to venture capital previously. The firm focuses on backing companies that have an alumni connection and are led by established institutional investors with expertise in their respective fields. Additionally, Alumni Ventures offers focused funds that enable accredited investors to access a diverse portfolio of investments across various types, sectors, stages, and geographies.
Senior Associate, Seed Fund and Doctors Innovate Fund
Drew Wandzilak
Senior Associate, Green D and Yard and Strategic Tech Fund
Sarah Worden
Venture Scout
Ray Wu
Managing Partner-Web3 / Blockchain Fund
Michael Yuann
Director of Investment Operations
Past deals in Predictive Analytics
Heymilo
Seed Round in 2025
Heymilo is a technology company that specializes in developing generative AI-powered voice agent platforms. Their primary product is a voice-based screening tool designed to streamline the hiring process for businesses. The platform conducts dynamic two-way conversations with job candidates, assessing their skills, communication abilities, and cultural fit. This enables clients to save time, reduce unconscious bias, and make more informed hiring decisions.
Dune Security
Seed Round in 2025
AI fighting AI. CISOs face an impossible risk landscape today. 80% of cybersecurity breaches start because of employee error. The problem is exacerbating with generative AI, as a single hacker can specifically target thousands of employees in the same amount of time that they used to specifically target tens of employees with social engineering. CISOs lack tools to deal with employee risk and are held accountable when a breach inevitably happens. By leveraging AI at each step, Dune Security empowers organizations to quantify individual risk through analyzing user behavior, context, learning patterns, and third party data. This allows the automation of tailored cybersecurity measures to each individual, transforming vulnerabilities into strengths. Dune is the central engine of all employee risk data, which is a solution that is not just timely for organizations but necessary in navigating the present cybersecurity landscape. This gives the CISO the capability to understand who are the high risk employees, to what extent, and why - as well as automatically remediate and restrict access to keep their organization safe. Today, Dune Security uniquely replaces legacy and ineffective security awareness training by pinpointing the crucial 8% of employees responsible for 80% of the risk, ensuring all employees receive personalized, machine learning-driven training tailored to their risk profile. CISOs also have easy access to quantifiable data via robust reporting and API-out capability, enabling them to both report to compliance auditors, regulators, and insurance underwriters, as well as restrict access to high-risk employees through other security systems.
Precision Neuroscience
Series C in 2024
Precision Neuroscience is a company focused on developing advanced brain-computer interface technology aimed at offering innovative treatments for the approximately one billion individuals worldwide affected by neurological disorders. Founded in 2021 and based in New York, the company's technology is characterized by its minimally invasive design, safety for removal, and capacity for processing substantial data. This platform enables medical professionals to establish a direct connection between the human brain and artificial intelligence, potentially transforming the landscape of neurological care.
MetaSight Diagnostics
Series A in 2024
MetaSight Diagnostics, a health technology company, is on a mission to develop affordable and precise liquid biopsy diagnostics for the early detection of a wide range of chronic and acute diseases by leveraging proprietary mass spectrometry technologies (metabolomics, lipidomics, and proteomics).
CytoVale
Series D in 2024
CytoVale, Inc. is a medical technology company based in San Francisco, California, established in 2012. The company specializes in developing biomarkers that leverage the mechanical properties of individual cells, a field known as mechanomics. By utilizing microfluidics technology, CytoVale can efficiently route and physically probe single cells to measure multiple biomarkers simultaneously. This innovative approach aims to enhance early detection of immune-mediated diseases, particularly sepsis, thereby improving patient outcomes and reducing treatment costs. CytoVale's integration of cell mechanics with machine learning positions it at the forefront of revolutionizing diagnostic practices in healthcare.
Centaur Labs
Series B in 2024
Centaur Labs specializes in medical data annotation services, aimed at enhancing medical decision-making and diagnostics. The company utilizes a platform that connects a global network of students and professionals, who compete to provide high-quality data labeling. This collaborative model ensures exceptional accuracy and scalability in annotating medical and scientific data. By analyzing medical cases and labeling data effectively, Centaur Labs contributes to the development of advanced medical AI technologies, ultimately helping patients achieve better healthcare outcomes while potentially reducing costs.
Infactory
Seed Round in 2024
Infactory is a developer of an artificial intelligence search tool aimed at providing reliable and accurate search results. The company's platform integrates quality data partnerships with both traditional and advanced technologies, allowing users to obtain clear and precise answers efficiently. Infactory focuses on enhancing the search experience by eliminating unnecessary complications, thereby ensuring users can trust the information they receive.
Distributional
Series A in 2024
Distributional is a developer of an AI testing and evaluation platform focused on ensuring that artificial intelligence systems are safe, reliable, and secure. The company offers tools for continuous monitoring, which include generating test cases and analyzing results. These tools help organizations ensure that their AI systems perform as expected, thereby fostering trust in AI technologies. By providing these capabilities, Distributional enables customers to deploy AI products more frequently and effectively, allowing them to fully leverage the potential benefits of AI within their operations.
Bionic Health
Seed Round in 2024
Bionic Health is a digital healthcare company focused on providing preventative health services, particularly for individuals experiencing chronic pain. The company has developed a platform that utilizes frequent diagnostics and machine learning to create personalized treatment plans. This approach emphasizes slowing down the aging process and offers patients tailored insights derived from ongoing assessments. By implementing an iterative journey, Bionic Health enables users to identify their unique health needs and make impactful lifestyle changes over time. Additionally, patients benefit from closely monitored preventative care throughout the year, enhancing their overall well-being.
BeyondTrucks
Series A in 2024
BeyondTrucks is a technology company focused on enhancing the operations of large private and specialty fleets through its innovative freight service platform. The platform facilitates process automation and optimization by integrating smart data, machine learning, and financial services, allowing businesses to replace outdated software and manual methods. This transition enables fleets to operate more efficiently and make informed decisions. BeyondTrucks aims to transform the logistics industry, which has been slow to adopt new technologies, by providing a comprehensive solution that connects various operational elements, thereby making transportation more driver-centric and manageable.
Knit
Series A in 2024
PurPics, LLC, based in Austin, Texas, operates a platform and application designed to connect brands with Gen Z consumers through student organizations. Founded in 2015, the platform enables members of these organizations to promote brand partners by posting pictures on their personal Instagram accounts. In return for increased engagement, brands can make donations for each like these posts receive. By customizing audience targeting based on factors such as region and campus, PurPics facilitates tailored marketing campaigns that enhance brand awareness and consumer interaction. This innovative approach offers brands a more effective means of engaging with their target demographics compared to traditional advertising methods. Through its SaaS-enabled marketplace, PurPics has collaborated with various brands to execute campaigns that drive foot traffic, boost in-store sales, and gather valuable consumer insights.
Multiscale Technologies
Series A in 2024
Multiscale Technologies is a company focused on transforming research and development in materials science through its advanced AI platform. This platform accelerates the discovery of new materials by a factor of 100, enabling manufacturing companies to optimize their R&D processes. It digitizes diverse data sources, including tabular data, PDFs, and simulations, and utilizes a unique knowledge fusion approach to integrate experimental results with domain expertise. By providing predictive analyses and actionable recommendations, the platform empowers scientists and engineers to create high-fidelity models that drive innovation across various research domains, ultimately facilitating advancements in materials development.
Clarium Health
Venture Round in 2024
Clarium is a company focused on enhancing healthcare operations through its artificial intelligence-based platform. This platform is designed to automate various business processes within healthcare settings by collecting and analyzing data from existing systems. It filters out noise, errors, and outliers to predict demand accurately, allowing healthcare providers to manage staffing and supplies more effectively. By enabling hospitals and healthcare centers to avoid shortages and stockouts, Clarium helps to reduce supplier lead times and identify alternative products, ultimately improving operational efficiency and patient care.
HeronAI
Pre Seed Round in 2024
HeronAI is a software company specializing in data analytics and visualization. Its platform employs artificial intelligence to transform raw data into actionable insights, generating dashboards and reports, and facilitating data-driven decision-making without necessitating technical expertise.
Consensus
Series A in 2024
The consensus is to enable discovery and consumption of the world's expert knowledge. No matter your background, finding scientific research has always been a difficult procedure. Consensus think AI has the potential to transform this equation if applied intelligently, deftly, and tastefully.
Hopscotch Primary Care
Series C in 2024
Operator of a data-driven healthcare startup intended to transform healthcare in rural communities through exceptional care, bringing better access and quality service to its patients. The company delivers tailored quality care through a team-based model, with resources and support for patients, inside and outside clinics, thereby enabling healthcare professionals to provide the support and care that patients need.
caVos biotherapeutics
Seed Round in 2024
An emerging genomic and data science company, developing novel drugs based on naturally occurring resistance mechanisms
Multitude Insights
Seed Round in 2024
Multitude Insights, founded in 2021 and based in Watertown, Massachusetts, specializes in providing law enforcement agencies with a document intelligence platform that enhances their ability to analyze unstructured data. The platform enables users to efficiently process large volumes of information related to suspects, issue bulletins, and track trends in real-time. Additionally, it improves search accuracy and facilitates collaboration among neighboring departments. By streamlining data analysis, Multitude Insights empowers public safety stakeholders to make informed decisions and enhance community safety.
NobleAI
Series A in 2024
NobleAI is a developer of a science-based artificial intelligence platform focused on enhancing the development of chemical and material products. By leveraging its advanced AI technology, NobleAI enables companies to streamline their materials development strategies, providing actionable insights and reliable predictions. This innovation helps reduce costs and accelerates the creation of new chemicals, materials, and formulations. As a result, businesses can innovate more rapidly and bring higher-performing, environmentally sustainable products to market more efficiently.
Truleo
Seed Round in 2024
Truleo is a developer of an audio analytics system focused on enhancing the review of police body camera footage, which often goes largely unexamined. The platform automatically processes 100% of body camera videos, significantly reducing the time required for review and offering valuable insights to improve policing practices. It analyzes interactions between police officers and civilians, detecting critical events such as use-of-force incidents and non-compliance. Truleo’s technology utilizes proprietary models created by law enforcement experts to identify trends in officer behavior, auto-flag incidents, and provide early warnings for potentially volatile situations. This capability enables law enforcement agencies to generate actionable reports that facilitate better officer training, inform policy decisions, and strengthen community relationships, while also highlighting positive officer interactions.
Century Health
Pre Seed Round in 2024
Century Health is a technology company that specializes in accelerating drug development and commercialization. It achieves this by harnessing the power of artificial intelligence (AI) to analyze real-world clinical data, which is often siloed and difficult to access. The company's platform connects to various disease-specific datasets, cleans and standardizes the data using AI, and enables researchers to efficiently analyze this real-world data. This process helps answer critical questions more rapidly, supports the research community, and ensures patient privacy is protected.
Ocient
Series B in 2024
Ocient Inc. is a Chicago-based company that specializes in analytical software solutions for database management. Founded in 2018, Ocient has developed a data analytics platform capable of rapidly analyzing massive datasets, ranging from tens of terabytes to exabytes, which can contain trillions or quadrillions of rows. The platform is designed to efficiently ingest billions of rows per second while filtering and computing aggregate results at speeds of up to trillions of rows per second. This capability allows organizations to effectively leverage large datasets, enabling them to gain insights at scale and with high velocity.
Mineral Forecast
Seed Round in 2024
Mineral Forecast is a company that leverages artificial intelligence to enhance the efficiency of mining exploration. It has developed a drilling support system that digitally transforms the mineral exploration process by analyzing exploration data. This innovative approach allows users to quantitatively rank potential drilling locations, significantly improving the chances of successful resource discovery. By utilizing advanced AI techniques, Mineral Forecast enables mining companies to optimize their drilling campaigns, ultimately reducing costs and accelerating the exploration timeline.
Alvee
Seed Round in 2024
Alvee is a developer of an artificial intelligence-driven tool designed to enhance health equity and improve health outcomes for patients. The tool offers real-time, patient-specific alerts that notify healthcare providers and payers when a patient has a confirmed or potential health equity issue. By integrating social determinants of health, chronic conditions, demographic information, and health inequity risks, Alvee provides a comprehensive view of a patient's health equity status. This enables healthcare providers and payers to meet data stratification quality reporting requirements effectively.
Lightbeam.ai
Series A in 2024
LightBeam.ai is a leader in data security and privacy automation, dedicated to helping organizations manage and access sensitive information securely. The company offers a platform that utilizes advanced data management, entity linkage techniques, and deep learning to analyze documents, speech, and natural language processing at scale. This technology integrates seamlessly with various data sources across industries, enabling clients to derive actionable insights while maintaining data privacy and confidentiality. By providing a unified control tower for data cataloging, access, and sharing, LightBeam empowers privacy and compliance executives to ensure continuous compliance, while information security professionals can trust that sensitive data is accessed and utilized securely.
Heymilo
Seed Round in 2024
Heymilo is a technology company that specializes in developing generative AI-powered voice agent platforms. Their primary product is a voice-based screening tool designed to streamline the hiring process for businesses. The platform conducts dynamic two-way conversations with job candidates, assessing their skills, communication abilities, and cultural fit. This enables clients to save time, reduce unconscious bias, and make more informed hiring decisions.
SpexAI
Seed Round in 2023
SpexAI is a precision farming company focused on large-scale cannabis producers, providing actionable insights through advanced spectral imaging technology. By developing smart multispectral sensors and an AI-driven platform, SpexAI enables growers to monitor cannabis plants in real-time, delivering critical data on cannabinoid levels, disease detection, and pest control. This innovative approach helps optimize cultivation processes, ensuring consistent harvests while minimizing waste and reducing costs. SpexAI's reliance on spectral data rather than intuition allows producers to make informed decisions throughout the growth cycle, ultimately enhancing the efficiency and quality of cannabis production.
Consensus
Seed Round in 2023
The consensus is to enable discovery and consumption of the world's expert knowledge. No matter your background, finding scientific research has always been a difficult procedure. Consensus think AI has the potential to transform this equation if applied intelligently, deftly, and tastefully.
Hayden AI
Series B in 2023
Hayden AI focuses on developing artificial intelligence and machine learning technologies aimed at enhancing urban mobility and safety. The company specializes in automated enforcement solutions for dedicated bus lanes and bus stops, which are designed to expedite public transit and improve the overall quality of life in urban areas. By leveraging advanced technology and a network of mobile devices, Hayden AI works to create safer and smarter cities. Its platform enables clients to utilize AI-powered tools that can detect and analyze traffic incidents, contributing to more efficient traffic management and fostering a sustainable urban environment.
Clarium Health
Seed Round in 2023
Clarium is a company focused on enhancing healthcare operations through its artificial intelligence-based platform. This platform is designed to automate various business processes within healthcare settings by collecting and analyzing data from existing systems. It filters out noise, errors, and outliers to predict demand accurately, allowing healthcare providers to manage staffing and supplies more effectively. By enabling hospitals and healthcare centers to avoid shortages and stockouts, Clarium helps to reduce supplier lead times and identify alternative products, ultimately improving operational efficiency and patient care.
CytoVale
Series C in 2023
CytoVale, Inc. is a medical technology company based in San Francisco, California, established in 2012. The company specializes in developing biomarkers that leverage the mechanical properties of individual cells, a field known as mechanomics. By utilizing microfluidics technology, CytoVale can efficiently route and physically probe single cells to measure multiple biomarkers simultaneously. This innovative approach aims to enhance early detection of immune-mediated diseases, particularly sepsis, thereby improving patient outcomes and reducing treatment costs. CytoVale's integration of cell mechanics with machine learning positions it at the forefront of revolutionizing diagnostic practices in healthcare.
OpsLab
Seed Round in 2023
OpsLab is a developer of an AI-based platform focused on predictive operations tracking and disruption management for industries such as airlines, hospitals, and defense organizations. The company creates enterprise software as a service (SaaS) products that utilize operations research techniques and machine learning to address complex optimization challenges. Its platform assists clients in managing operational planning, tracking, and recovery processes, particularly in the airline sector where it automates crew scheduling and enhances ground staff management. By leveraging advanced technologies, OpsLab aims to improve efficiency and resilience in critical operations across various sectors.
OfferFit
Series B in 2023
OfferFit is an AI-powered experimentation platform that automates decision-making and personalization for businesses, enhancing customer engagement strategies through continuous testing and learning. The platform employs machine learning to create a self-learning decision engine that segments customers and identifies the most suitable offers for each group. This approach enables businesses to send personalized promotions, improving marketing effectiveness and customer experience. By analyzing customer responses, OfferFit helps companies refine their strategies and optimize the profitability of their promotions.
Graft
Seed Round in 2023
Graft is a modern AI platform that allows data teams to create production-ready AI solutions with minimal effort. It eliminates the need for machine learning expertise, additional staffing, or infrastructure maintenance. The platform focuses on a data-centric approach, utilizing foundation models to enhance business outcomes. Additionally, Graft specializes in unstructured data analysis, harnessing artificial intelligence to process various types of data, including text, images, video, audio, and graphs. This capability enables clients to apply advanced analytical techniques effectively, ultimately driving improved results for their businesses.
Onwish
Seed Round in 2023
Onwish is a technology company that develops an AI platform for financial research. This platform uses advanced large language models to provide on-demand, in-depth analysis, presenting data in both textual and visual formats. A key feature is the ability to verify AI-generated content by directly citing sources and highlighting excerpts from original documents.
Ellipsis Health
Series A in 2023
Ellipsis Health, Inc. is a technology company based in San Francisco, California, founded in 2013. It specializes in developing analytics solutions that utilize artificial intelligence to enhance behavioral health assessments by analyzing patient speech and clinical data. The company's platform offers a behavioral biomarker technology that generates clinical-grade evaluations of anxiety and depression severity, as well as sub-clinical assessments of stress. This innovative approach allows healthcare systems to continuously monitor their patient populations for mental health conditions, particularly depression, and facilitates timely support for patients in need. By integrating affective computing into patient and care team interactions, Ellipsis Health aims to create real-time behavioral health vital signs for improved patient outcomes.
Coframe
Seed Round in 2023
Coframe is a technology company that specializes in AI-driven A/B testing and personalization for websites and applications. Its platform continuously analyzes user interactions to optimize content, improving user experience, engagement, and conversion rates. Coframe's solution involves training multimodal models to understand user behavior and business goals, enabling user interfaces to autonomously enhance themselves over time.
Jericho Security
Seed Round in 2023
Jericho Security specializes in cybersecurity, focusing on protecting businesses from emerging threats posed by generative AI. The company's core product, cyberGPT, is a proprietary generative AI that simulates real-world cyberattacks, aids in developing new defenses, and provides personalized training to enhance cybersecurity efficiency and prevent potential threats.
Jericho Security
Pre Seed Round in 2023
Jericho Security specializes in cybersecurity, focusing on protecting businesses from emerging threats posed by generative AI. The company's core product, cyberGPT, is a proprietary generative AI that simulates real-world cyberattacks, aids in developing new defenses, and provides personalized training to enhance cybersecurity efficiency and prevent potential threats.
AlliConnect
Seed Round in 2023
Alli Connect is a breakthrough B2B software for patient provider matching in mental health care. Our powerful technology proactively promotes wellness, improves patient clinical outcomes and eliminates the trial and error currently utilized in seeking treatment. Alli Connect’s platform is customized to each individual customer organization to drive high engagement and quantify effectiveness in access to care. The data gathered by the Alli Connect technology provides the ability to make data driven decision in mental health for Value Based Care. Our unique approach and technology has been validated by more than 5 years of data, increasing success in access to mental health care from 19% to 88%! Alli Connect was founded and is led by Colleen Hilton, a 2x founder and licensed mental health provider; with the unique industry knowledge required to successfully tackle the healthcare business market.
Dune Security
Pre Seed Round in 2023
AI fighting AI. CISOs face an impossible risk landscape today. 80% of cybersecurity breaches start because of employee error. The problem is exacerbating with generative AI, as a single hacker can specifically target thousands of employees in the same amount of time that they used to specifically target tens of employees with social engineering. CISOs lack tools to deal with employee risk and are held accountable when a breach inevitably happens. By leveraging AI at each step, Dune Security empowers organizations to quantify individual risk through analyzing user behavior, context, learning patterns, and third party data. This allows the automation of tailored cybersecurity measures to each individual, transforming vulnerabilities into strengths. Dune is the central engine of all employee risk data, which is a solution that is not just timely for organizations but necessary in navigating the present cybersecurity landscape. This gives the CISO the capability to understand who are the high risk employees, to what extent, and why - as well as automatically remediate and restrict access to keep their organization safe. Today, Dune Security uniquely replaces legacy and ineffective security awareness training by pinpointing the crucial 8% of employees responsible for 80% of the risk, ensuring all employees receive personalized, machine learning-driven training tailored to their risk profile. CISOs also have easy access to quantifiable data via robust reporting and API-out capability, enabling them to both report to compliance auditors, regulators, and insurance underwriters, as well as restrict access to high-risk employees through other security systems.
Limitless
Series A in 2023
Rewind is a personalized AI powered by everything you’ve seen, said, or heard.
DropStat
Venture Round in 2023
DropStat is a technology company that offers an app-based platform designed to optimize staffing for hospitals. Founded in 2017 and headquartered in Beverly Hills, California, DropStat utilizes artificial intelligence and machine learning to predict and autonomously fill staffing gaps, allowing healthcare facilities to manage labor costs more effectively. By streamlining the process of calling staff for open shifts, the platform eliminates the need for traditional communication methods such as calls and texts, thereby enhancing efficiency and reducing financial waste. In addition to improving operational processes, DropStat prioritizes data security, ensuring that sensitive information is protected both in the system and during transmission. The company's mission is to modernize shift communication, ultimately aiming to enhance both patient and staff satisfaction.
Consensus
Seed Round in 2023
The consensus is to enable discovery and consumption of the world's expert knowledge. No matter your background, finding scientific research has always been a difficult procedure. Consensus think AI has the potential to transform this equation if applied intelligently, deftly, and tastefully.
NobleAI
Series A in 2023
NobleAI is a developer of a science-based artificial intelligence platform focused on enhancing the development of chemical and material products. By leveraging its advanced AI technology, NobleAI enables companies to streamline their materials development strategies, providing actionable insights and reliable predictions. This innovation helps reduce costs and accelerates the creation of new chemicals, materials, and formulations. As a result, businesses can innovate more rapidly and bring higher-performing, environmentally sustainable products to market more efficiently.
Bionic Health
Seed Round in 2023
Bionic Health is a digital healthcare company focused on providing preventative health services, particularly for individuals experiencing chronic pain. The company has developed a platform that utilizes frequent diagnostics and machine learning to create personalized treatment plans. This approach emphasizes slowing down the aging process and offers patients tailored insights derived from ongoing assessments. By implementing an iterative journey, Bionic Health enables users to identify their unique health needs and make impactful lifestyle changes over time. Additionally, patients benefit from closely monitored preventative care throughout the year, enhancing their overall well-being.
Precision Neuroscience
Series B in 2023
Precision Neuroscience is a company focused on developing advanced brain-computer interface technology aimed at offering innovative treatments for the approximately one billion individuals worldwide affected by neurological disorders. Founded in 2021 and based in New York, the company's technology is characterized by its minimally invasive design, safety for removal, and capacity for processing substantial data. This platform enables medical professionals to establish a direct connection between the human brain and artificial intelligence, potentially transforming the landscape of neurological care.
Beekin
Seed Round in 2023
Beekin is a developer of a real estate analytics platform that offers prescriptive analytics for multifamily and single-family operations. It provides institutional-scale investment management solutions, enabling clients to harness vast amounts of data for informed decision-making in real estate investments. The platform delivers real-time insights on valuations, contract management, accounting, and reporting, helping clients optimize their investments effectively. Trusted by some of the world's largest family offices and private funds, Beekin manages over $5 billion in real estate assets daily, generating significant financial returns. The company combines expertise in data science with a deep understanding of real estate, supported by a team of urban economists and AI professionals. Through collaboration and a commitment to transparency, Beekin aims to enhance efficiency and drive innovation in the real estate sector.
Solvo.ai
Seed Round in 2022
Solvo.ai is a developer of an artificial intelligence-based platform focused on enhancing the resilience, efficiency, and responsiveness of global supply chains. By integrating human expertise with practical AI, the company aims to create a centralized decision-making framework that allows organizations to navigate complex supply chain challenges. Its optimization engine is designed to run various scenarios, assess trade-offs, and improve transparency, enabling businesses to adapt swiftly to market changes, disruptions, and evolving customer behaviors. This approach not only helps in managing risks but also supports businesses in achieving better operational yields. Solvo.ai’s mission centers on addressing real-world supply chain issues through innovative and value-driven machine learning technology.
Multiscale Technologies
Venture Round in 2022
Multiscale Technologies is a company focused on transforming research and development in materials science through its advanced AI platform. This platform accelerates the discovery of new materials by a factor of 100, enabling manufacturing companies to optimize their R&D processes. It digitizes diverse data sources, including tabular data, PDFs, and simulations, and utilizes a unique knowledge fusion approach to integrate experimental results with domain expertise. By providing predictive analyses and actionable recommendations, the platform empowers scientists and engineers to create high-fidelity models that drive innovation across various research domains, ultimately facilitating advancements in materials development.
PathSpot
Series A in 2022
PathSpot Technologies, Inc., established in 2017 and headquartered in New York City, specializes in food safety solutions. The company develops and manufactures a unique system that uses a proprietary algorithm to analyze fluorescent light, enabling it to scan employees' hands and detect pathogens that cause food-borne illnesses. This technology helps restaurants and their customers mitigate the risk of food-borne illnesses by providing instant, invisible signs of harmful bacteria and viruses.
Kalderos
Venture Round in 2022
Kalderos, Inc. is a company that specializes in drug discount management solutions for various stakeholders in the U.S. healthcare system, including providers, manufacturers, and payers. Established in 2016 and headquartered in Chicago, Illinois, with an additional location in Brookfield, Wisconsin, Kalderos offers a software-as-a-service (SaaS) platform designed to analyze and streamline the complex coordination of drug discount programs. The platform employs advanced models and machine learning to identify and resolve non-compliance issues, detecting inconsistencies that traditional methods often miss. By providing data management capabilities and customizable insights, Kalderos enables clients to enhance their processes for claims verification, dispute resolution, and discount monitoring, ultimately reducing waste and improving operational efficiency.
Knowde
Series A in 2022
Knowde operates an online marketplace focused on the chemical industry, enhancing the accessibility of trading chemicals, polymers, and industrial ingredients. Its platform utilizes advanced technologies, including deep learning and self-learning data models, to facilitate the search, filtering, sampling, quoting, and purchasing of products tailored to client specifications. By offering a comprehensive chemical taxonomy, Knowde empowers global chemical producers and distributors to transform their operations digitally. This innovative approach allows clients to compare and access products from suppliers worldwide, streamlining the procurement process in the chemical sector. The company has garnered support from prominent investors, highlighting its potential in revolutionizing how chemical transactions are conducted.
Arable
Series C in 2022
Arable Labs, Inc. specializes in developing a solar-powered Internet of Things (IoT) device equipped with advanced sensors for in-field crop monitoring. This technology allows farmers to digitize and optimize their agricultural decisions by providing critical data about the impact of weather and other factors on crop yield, quality, and harvest timing. Arable's integrated system combines unique spectral and thermal sensors with agronomic modeling and software tools, enabling users to monitor crop development and identify stressors such as water or nutrient deficiencies. The platform serves a diverse clientele, including farmers, agronomists, researchers, food processors, and agricultural enterprises, facilitating real-time insights and predictive analytics that enhance productivity and sustainability. Established in 2014, Arable is headquartered in San Francisco, California, with an additional office in Princeton, New Jersey. The company has received various accolades, highlighting its innovation in agricultural technology.
Moving Analytics
Series A in 2022
Moving Analytics is a telehealth service provider that specializes in cardiovascular prevention programs. Its first product Movn is an end-to-end, integrated program to deliver remote and virtual cardiac rehab. The platform reduces readmissions and empowers the effective and efficient delivery of quality care to patients based on 30+ years of research in remote disease management from Stanford University.
Veritonic
Series A in 2022
Veritonic, Inc. is a marketing analytics company based in New York that specializes in audio research and analytics. Founded in 2015, Veritonic offers a platform designed to measure, compare, and test various audio assets, including music, voiceovers, and jingles, to assess their effectiveness across different audience segments. The platform provides qualitative and quantitative insights into marketing responses, allowing brands, agencies, and publishers to evaluate the return on investment (ROI) of their audio campaigns before, during, and after execution. By leveraging artificial intelligence metrics, Veritonic helps clients optimize their audio marketing strategies, mitigate risks, and enhance consumer engagement through impactful audio experiences.
Knit
Seed Round in 2022
PurPics, LLC, based in Austin, Texas, operates a platform and application designed to connect brands with Gen Z consumers through student organizations. Founded in 2015, the platform enables members of these organizations to promote brand partners by posting pictures on their personal Instagram accounts. In return for increased engagement, brands can make donations for each like these posts receive. By customizing audience targeting based on factors such as region and campus, PurPics facilitates tailored marketing campaigns that enhance brand awareness and consumer interaction. This innovative approach offers brands a more effective means of engaging with their target demographics compared to traditional advertising methods. Through its SaaS-enabled marketplace, PurPics has collaborated with various brands to execute campaigns that drive foot traffic, boost in-store sales, and gather valuable consumer insights.
Quadrant Health
Pre Seed Round in 2022
Quadrant Health, founded in 2021 by Krishna Gorrepati and Anin Sayana, specializes in providing real-time analysis of electronic health records (EHR) and patient messaging data. The company has developed a cloud-based disease prediction platform that employs machine learning algorithms to identify potential health risks, such as infections and injuries, before symptoms manifest. This innovative approach enables healthcare providers to proactively manage patient care, enhancing their ability to prevent harm and improve overall patient outcomes. By focusing on early detection, Quadrant Health aims to transform preventative medicine and support healthcare professionals in delivering more effective care.
BeyondTrucks
Seed Round in 2022
BeyondTrucks is a technology company focused on enhancing the operations of large private and specialty fleets through its innovative freight service platform. The platform facilitates process automation and optimization by integrating smart data, machine learning, and financial services, allowing businesses to replace outdated software and manual methods. This transition enables fleets to operate more efficiently and make informed decisions. BeyondTrucks aims to transform the logistics industry, which has been slow to adopt new technologies, by providing a comprehensive solution that connects various operational elements, thereby making transportation more driver-centric and manageable.
GridMatrix
Seed Round in 2022
GridMatrix develops software aimed at alleviating traffic congestion, reducing emissions, and enhancing safety in urban environments. By leveraging existing infrastructure, such as intersection cameras and other sensors, GridMatrix provides real-time insights and analytics that optimize intersection efficiency. The software processes data from these sources in conjunction with cloud-based mobility information, allowing cities to autonomously manage traffic flow, adaptively time traffic signals, and anticipate potential congestion and accidents. This innovative approach enables urban areas to improve overall traffic management and safety while minimizing environmental impact.
Odaia
Series A in 2022
ODAIA is a company that has developed an AI-powered Customer Data Platform specifically for the Life Sciences industry. This innovative platform integrates process mining, customer journey mapping, and artificial intelligence to provide commercial insights and automate processes. By leveraging data analysis, ODAIA's solution enables pharmaceutical commercial teams to enhance personalized selling and ensure that therapeutics reach the patients who require them. The platform aims to streamline decision-making and improve the effectiveness of commercial strategies in the healthcare sector.
Curbside Health
Seed Round in 2022
Curbside Health develops clinical decision support software that aligns health systems and clinicians to more efficiently deliver optimal care. The company was founded by physicians and technologists to combine the best of clinical evidence with the realities of healthcare delivery and with opportunities of modern web technology. We support health systems and hospitals to expand their clinical content library (e.g. clinical pathways, protocols, guidelines, A3s, checklists, etc) and enhance the utilization of these resources at the point-of-care. Together, the components of Curbside's platform enable a hospital to improve clinical outcomes and operational efficiencies. Product development is informed by working closely with patients, clinicians, engineers, physicians, healthcare administrators, and payors. Our mission is hiding in plain sight within our name, and those in healthcare will understand: every medical decision is informed in real-time by the world's expert of that particular situation, while simultaneously accounting for hospital policy and all relevant patient-specific data. Essentially, Curbside is on a never-ending quest to perfect medical decision making.
AlliConnect
Seed Round in 2022
Alli Connect is a breakthrough B2B software for patient provider matching in mental health care. Our powerful technology proactively promotes wellness, improves patient clinical outcomes and eliminates the trial and error currently utilized in seeking treatment. Alli Connect’s platform is customized to each individual customer organization to drive high engagement and quantify effectiveness in access to care. The data gathered by the Alli Connect technology provides the ability to make data driven decision in mental health for Value Based Care. Our unique approach and technology has been validated by more than 5 years of data, increasing success in access to mental health care from 19% to 88%! Alli Connect was founded and is led by Colleen Hilton, a 2x founder and licensed mental health provider; with the unique industry knowledge required to successfully tackle the healthcare business market.
AlliConnect
Seed Round in 2022
Alli Connect is a breakthrough B2B software for patient provider matching in mental health care. Our powerful technology proactively promotes wellness, improves patient clinical outcomes and eliminates the trial and error currently utilized in seeking treatment. Alli Connect’s platform is customized to each individual customer organization to drive high engagement and quantify effectiveness in access to care. The data gathered by the Alli Connect technology provides the ability to make data driven decision in mental health for Value Based Care. Our unique approach and technology has been validated by more than 5 years of data, increasing success in access to mental health care from 19% to 88%! Alli Connect was founded and is led by Colleen Hilton, a 2x founder and licensed mental health provider; with the unique industry knowledge required to successfully tackle the healthcare business market.
OfferFit
Series A in 2021
OfferFit is an AI-powered experimentation platform that automates decision-making and personalization for businesses, enhancing customer engagement strategies through continuous testing and learning. The platform employs machine learning to create a self-learning decision engine that segments customers and identifies the most suitable offers for each group. This approach enables businesses to send personalized promotions, improving marketing effectiveness and customer experience. By analyzing customer responses, OfferFit helps companies refine their strategies and optimize the profitability of their promotions.
TripleBlind
Series A in 2021
TripleBlind, Inc. is a Kansas City-based company incorporated in 2019 that provides an online platform enabling organizations to collaborate while safeguarding sensitive data and algorithms. The company specializes in privacy-enhancing computation, offering a software-only solution delivered through a simple API. TripleBlind focuses on sectors such as healthcare and financial services, utilizing innovations like federated learning and multi-party computation to enhance the scalability and efficiency of privacy-preserving technology. Its platform allows institutions to share and monetize regulated data without compromising privacy, ensuring compliance with regulations like HIPAA and GDPR. By facilitating collaboration around sensitive data without decryption, TripleBlind enables clients to generate new revenue, derive deeper insights, and improve modeling and analysis. The company is supported by notable investors including Accenture, General Catalyst, and The Mayo Clinic, and it integrates seamlessly with major cloud platforms.
Civis Analytics
Series B in 2021
Civis Analytics, Inc. is a data science software company that empowers organizations to make data-driven decisions. Founded in 2013 and based in Chicago, Illinois, Civis offers a range of tools designed to enhance data analysis and audience engagement. Its Civis platform provides predictive analytics capabilities, facilitating end-to-end data science workflows. Key offerings include the Community Outreach and Engagement Hub, which assists government and nonprofit teams in effectively reaching and influencing their target audiences, and the Census Intelligence Center, a resource for supporting census efforts. Additionally, the company features tools such as the Audience Center for customer targeting, Creative Focus for message testing, and Civis Media Optimizer for optimizing TV advertising strategies. Civis Analytics also delivers consumer insights, market research, and data science consulting services, helping clients leverage data to gain a competitive edge in their operations.
Olaris
Series B in 2021
Olaris is dedicated to transforming disease diagnosis and treatment through its innovative CEREBRO platform, which integrates metabolomics and machine learning. This platform focuses on the Comprehensive Early Responsive Evaluation of Biomarkers Related to Outcomes, enabling the identification of biomarkers that can optimize patient treatment. By developing the myOLARIS™ precision diagnostics, Olaris aims to match the right drug to the right patient, enhancing clinical outcomes while minimizing adverse events. Founded in 2013 and headquartered in Framingham, Massachusetts, the company collaborates with healthcare providers to improve patient care through advanced diagnostic solutions.
Nixtla
Pre Seed Round in 2021
Nixtla is a software development company focused on providing advanced forecasting tools for businesses of all sizes and across various industries. The company aims to democratize access to sophisticated data-driven decision-making solutions by offering an open-source platform that allows developers and data scientists to create and manage time series processing services in the cloud. Nixtla's technology facilitates continuous integration and deployment, enabling clients to implement cutting-edge forecasting and anomaly detection features without requiring extensive technical expertise. By unlocking the potential of data, Nixtla helps organizations reduce uncertainty and make informed decisions.
Hayden AI
Series A in 2021
Hayden AI focuses on developing artificial intelligence and machine learning technologies aimed at enhancing urban mobility and safety. The company specializes in automated enforcement solutions for dedicated bus lanes and bus stops, which are designed to expedite public transit and improve the overall quality of life in urban areas. By leveraging advanced technology and a network of mobile devices, Hayden AI works to create safer and smarter cities. Its platform enables clients to utilize AI-powered tools that can detect and analyze traffic incidents, contributing to more efficient traffic management and fostering a sustainable urban environment.
Shakudo
Seed Round in 2021
Shakudo is a company that offers an end-to-end machine learning platform aimed at simplifying the management of data stacks for artificial intelligence teams. By creating compatibility among various top-tier data tools, Shakudo enhances the reliability and performance of data management while reducing costs. The platform allows AI teams to efficiently transition from ideation to production, enabling them to scale and customize clusters with minimal coding. This capability empowers data science and machine learning teams to deliver tangible products rather than mere experimental outcomes, thereby decreasing their dependency on engineering resources to bring research to market.
AdaptX
Series A in 2021
AdaptX is a healthcare data analytics and AI company that specializes in enhancing clinical and workflow outcomes for hospitals and surgery centers. Founded in Seattle in 2016 as a spin-off from Seattle Children's Hospital, AdaptX provides a platform that enables medical leaders and clinicians to access and analyze clinical data effectively. The platform integrates algorithms with existing electronic data systems, allowing healthcare providers to monitor performance, compare treatment approaches, and define patient cohorts. Through automated analytics, AdaptX helps healthcare service providers improve the quality and safety of care while also reducing costs.
Pave
Seed Round in 2021
Pave helps consumer and SMB credit risk teams increase approvals through AI-powered cashflow analytics. 100 million+ US consumers and businesses are financially underserved, simply because their data is not recognized by the traditional financial system. We solve this by transforming transaction data, loan performance outcomes, and credit reports into Cashflow-driven Attributes and Scores, enabling increased financial access to new customer segments without increasing risk. Our mission is to build a future where every person and business has access to equitable credit solutions by creating a new standard of Cashflow-driven Analytics.
Zone7
Convertible Note in 2021
Zone7 is a technology company founded in 2017 and based in Palo Alto, California, specializing in artificial intelligence-driven sports injury prediction software. The platform leverages data from wearable devices, medical records, and fitness profiles to forecast potential injuries, allowing for proactive measures to enhance athlete safety and performance. Zone7 serves over 30 professional sports franchises, offering insights that enable coaching staff to monitor athlete performance and injury risk effectively. Additionally, the technology is utilized in hospitals to ensure the well-being of medical staff by providing actionable recommendations for optimizing workload and recovery. By analyzing various data sources, Zone7 aims to protect and enhance the health and performance of both athletes and the elite workforce.
Intrinio
Series B in 2021
Intrinio is a financial data company that provides an accessible platform for investors and developers through its application programming interface. The company's mission is to simplify financial data access, enabling users to save time and reduce costs associated with data collection and analysis. By offering a variety of financial data feeds, including fundamentals, economic indicators, insider transactions, and stock prices, Intrinio facilitates valuable insights from SEC filings in user-friendly formats. This approach empowers developers to create innovative financial analytics products while allowing investors to focus on research, testing assumptions, and generating insights. Intrinio aims to reshape the financial data landscape by fostering collaboration among data providers, developers, and investors, ultimately enhancing the overall financial innovation ecosystem.
Datanomix
Series A in 2021
Datanomix, Inc. is a software company based in Nashua, New Hampshire, that specializes in providing a machine data analytics platform for industrial manufacturers. Founded in 2015, Datanomix focuses on delivering Production Intelligence, enabling manufacturers to gain real-time insights into their productivity and operational performance. The platform integrates machine data streams, offering advanced decision-making tools that extend beyond traditional data visualization and process productivity solutions. This allows manufacturers of all sizes to enhance their production capabilities, improve performance, and increase profitability.
Intus Care
Seed Round in 2021
Intus Care, Inc. is a healthcare analytics platform focused on improving patient care and reducing hospitalizations for vulnerable and complex patients. Founded in 2018 and based in North Providence, Rhode Island, the company connects home care providers to patients through an application that tracks provider efficiency via electronic visit verification. Utilizing machine learning, the platform predicts hospital readmissions and identifies patients at high risk for hospitalizations. It also facilitates automatic patient risk grouping, enables care coordination teams to receive notifications about changes in patient health status, and supports the development of data-driven interventions and care plans. By synthesizing financial, clinical, and administrative data, Intus Care helps organizations such as nursing homes, PACE programs, and home care agencies visualize healthcare trends, ultimately aiming to deliver cost-effective healthcare solutions.
PulseData AI
Series A in 2021
PulseData AI, established in 2015 and headquartered in New York, specializes in healthcare technology. It develops machine learning software that helps healthcare providers identify patients at high risk of adverse, preventable medical outcomes. The company's platform analyzes vast amounts of patient data to predict health trends, enabling care management teams to deliver timely, targeted interventions and improve overall patient outcomes.
Scipher Medicine
Series C in 2021
Scipher Medicine Corporation is a biotechnology company based in Waltham, Massachusetts, that specializes in precision medicine for patients with autoimmune and cardiovascular diseases. The company has developed a molecular technology platform that utilizes blood samples to analyze RNA and predict patient responses to drug therapies. Its primary offerings include PrismDx tests, which identify patients who may not respond to certain medications, ensuring they can be prescribed alternative treatments. Notably, the PrismRA test assesses patients with rheumatoid arthritis to determine their likelihood of responding to anti-TNF therapies, while PrismUC serves a similar purpose for patients with ulcerative colitis. By focusing on the underlying disease biology rather than just symptoms, Scipher Medicine aims to optimize treatment from the outset, potentially reducing the healthcare costs associated with ineffective therapies. Established in 2013 and rebranded in 2015, Scipher Medicine is committed to transforming drug prescription practices and advancing drug development through its innovative approach.
Hayden AI
Seed Round in 2021
Hayden AI focuses on developing artificial intelligence and machine learning technologies aimed at enhancing urban mobility and safety. The company specializes in automated enforcement solutions for dedicated bus lanes and bus stops, which are designed to expedite public transit and improve the overall quality of life in urban areas. By leveraging advanced technology and a network of mobile devices, Hayden AI works to create safer and smarter cities. Its platform enables clients to utilize AI-powered tools that can detect and analyze traffic incidents, contributing to more efficient traffic management and fostering a sustainable urban environment.
Lang.ai
Seed Round in 2021
Lang.ai is a language understanding platform that automates the processing and analysis of unstructured text from customer interactions. Founded in 2012 and headquartered in Madrid, Spain, with additional offices in the United States and Mexico, the company utilizes artificial intelligence to enhance support conversations. Its technology allows users to automatically tag and categorize customer interactions, enabling the identification of patterns within their data. The platform features capabilities such as intent customization, real-time self-supervised classification, and algorithmic preprocessing, which facilitate tokenization, lemmatization, and intent induction. By streamlining these processes, Lang.ai helps businesses optimize costs and improve efficiency in managing customer communications.
Ocient
Series B in 2021
Ocient Inc. is a Chicago-based company that specializes in analytical software solutions for database management. Founded in 2018, Ocient has developed a data analytics platform capable of rapidly analyzing massive datasets, ranging from tens of terabytes to exabytes, which can contain trillions or quadrillions of rows. The platform is designed to efficiently ingest billions of rows per second while filtering and computing aggregate results at speeds of up to trillions of rows per second. This capability allows organizations to effectively leverage large datasets, enabling them to gain insights at scale and with high velocity.
Mage
Seed Round in 2021
Mage is a developer of an open-source coding tool that empowers businesses to leverage artificial intelligence for predictive analytics. The platform enables users to create and deploy machine-learning models efficiently, allowing for applications in areas such as churn prevention, product recommendations, and customer lifetime value assessment. By facilitating the import and transformation of data from various sources, Mage's technology simplifies the process of building, training, and integrating data into applications. The company's mission is to make AI technology accessible, enabling businesses to enhance customer experiences through innovative solutions.
FULLFILL
Seed Round in 2021
FULLFILL is a digital health platform focused on providing virtual health coaching aimed at treating and preventing chronic conditions. Founded in 2019 and headquartered in Los Angeles, the company partners with employers to enhance employee health and reduce medical expenses. FULLFILL's evidence-based programs have demonstrated significant effectiveness, achieving double the medical results of competing programs and tenfold employee sign-up rates. The platform offers a comprehensive range of resources, including daily videos, podcasts, articles, workouts, and meal plans, all accessible online with 24/7 support from trained Master Coaches. FULLFILL's approach not only addresses issues like obesity, diabetes, and mental health but also boosts participation in other health initiatives offered by employers, while its services qualify as a medical expense. The program has garnered high satisfaction ratings, positioning it as a valuable tool for employee retention amid increasing health challenges, especially in the wake of COVID-19.
Conversa Health
Series B in 2021
Conversa Health, Inc. specializes in patient relationship management solutions aimed at enhancing communication between patients and healthcare teams. The company's flagship offering, the Conversa Virtual Care and Communication Platform, streamlines patient engagement and improves health outcomes through automated, personalized messaging based on comprehensive patient profiles derived from electronic health records, biometric devices, and self-reported data. This platform enables health systems, pharmaceutical companies, and payers to shift from reactive communication to proactive engagement, facilitating better management of chronic conditions, acute discharges, and preventive care. Conversa also provides Digital Checkups, which generate tailored clinical questions and alerts based on individual patient data, and Conversa Connect, a patient profiling and health signals engine. Established in 2013 and headquartered in Portland, Oregon, with additional offices in New York, North Carolina, and California, Conversa Health serves a diverse clientele, including healthcare providers, health systems, and health technology companies.
Ellipsis Health
Seed Round in 2021
Ellipsis Health, Inc. is a technology company based in San Francisco, California, founded in 2013. It specializes in developing analytics solutions that utilize artificial intelligence to enhance behavioral health assessments by analyzing patient speech and clinical data. The company's platform offers a behavioral biomarker technology that generates clinical-grade evaluations of anxiety and depression severity, as well as sub-clinical assessments of stress. This innovative approach allows healthcare systems to continuously monitor their patient populations for mental health conditions, particularly depression, and facilitates timely support for patients in need. By integrating affective computing into patient and care team interactions, Ellipsis Health aims to create real-time behavioral health vital signs for improved patient outcomes.
OmniPanel
Seed Round in 2020
OmniPanel operates an analytics platform designed to extract insights from customer support tickets. By analyzing these tickets, the platform helps businesses identify factors that influence customer retention and profitability. It enables clients to understand user friction points and enhances their approach to customer experience by prioritizing the customer's voice. This focus allows businesses to make informed product decisions and improve customer service engagement.
Market AI
Seed Round in 2020
Market AI has been acquired by Verishop Group! Learn more about Verishop Group: https://www.verishopgroup.com/
FreightFlows
Venture Round in 2020
FreightFlows, Inc. is a maritime market intelligence company based in Boston, Massachusetts, founded in 2018. It specializes in providing predictive analytics for global trade, focusing on the needs of traders, shippers, owners, and brokers. The company has developed a data platform that sources, synthesizes, and analyzes current market data, enabling users to explore trends in market, port, and fleet activities. This platform allows clients to identify vessel availability, routes, and estimated time of arrival, while also gaining visibility into commodity cargoes and trade activities. Additionally, FreightFlows offers market analysis services to help clients navigate futures markets, manage commercial risks, and hedge against freight rate volatility.
Civis Analytics
Series A in 2020
Civis Analytics, Inc. is a data science software company that empowers organizations to make data-driven decisions. Founded in 2013 and based in Chicago, Illinois, Civis offers a range of tools designed to enhance data analysis and audience engagement. Its Civis platform provides predictive analytics capabilities, facilitating end-to-end data science workflows. Key offerings include the Community Outreach and Engagement Hub, which assists government and nonprofit teams in effectively reaching and influencing their target audiences, and the Census Intelligence Center, a resource for supporting census efforts. Additionally, the company features tools such as the Audience Center for customer targeting, Creative Focus for message testing, and Civis Media Optimizer for optimizing TV advertising strategies. Civis Analytics also delivers consumer insights, market research, and data science consulting services, helping clients leverage data to gain a competitive edge in their operations.
Chooch
Series A in 2020
Chooch specializes in generative AI technology that integrates computer vision and language understanding to enhance the intelligence of cameras. Its AI Vision platform is capable of instantaneously recognizing visuals and actions within video streams, understanding their significance, and executing real-time pre-programmed responses. This advanced system operates autonomously, processing diverse forms of visual data, including infrared radiation and x-rays, while tagging objects of interest. By delivering accurate and efficient visual recognition, Chooch enables clients to achieve enhanced operational efficiencies and improved quality outcomes.
Unlearn.AI
Series A in 2020
Unlearn.AI, Inc. is a biotechnology company that specializes in developing software tools for clinical research, focusing on improving diagnosis and treatment processes. Based in San Francisco, the company offers solutions such as Clinical Trial Design, which helps define inclusion criteria, endpoints, and study sizes; Synthetic Control Arms, which reduce or eliminate the necessity for concurrent control groups; and Subgroup Analysis, which identifies specific patient subgroups within trial results. Unlearn.AI has pioneered the TwinRCT solution, a digital twin service that leverages machine learning to enhance the efficiency and success rates of clinical trials. This innovative approach creates a prognostic digital twin for each patient, allowing for more precise estimations of treatment effects based on historical data. By integrating machine learning and biostatistics, Unlearn.AI aims to accelerate the clinical trial process, benefiting both patients and pharmaceutical sponsors.
Usermind
Series C in 2020
Usermind, Inc. is a technology company that offers a unified orchestration platform aimed at enhancing business operations and customer journeys. Established in 2013 and headquartered in Seattle, Washington, Usermind addresses issues associated with siloed enterprise systems and fragmented customer data. Its platform integrates various SaaS applications and on-premise systems, facilitating entity mapping and automating complex customer interactions. Additionally, it provides comprehensive analytics on business processes, which empowers companies to deliver data-driven, omnichannel customer engagement throughout the entire customer lifecycle. Usermind's solutions enable businesses to optimize personalized interactions, enhance customer experiences, and ultimately drive revenue growth while reducing costs. The company was founded by technology veterans Michel Feaster and Przemek Pardyak and is supported by prominent venture capital firms.
Arable
Series B in 2020
Arable Labs, Inc. specializes in developing a solar-powered Internet of Things (IoT) device equipped with advanced sensors for in-field crop monitoring. This technology allows farmers to digitize and optimize their agricultural decisions by providing critical data about the impact of weather and other factors on crop yield, quality, and harvest timing. Arable's integrated system combines unique spectral and thermal sensors with agronomic modeling and software tools, enabling users to monitor crop development and identify stressors such as water or nutrient deficiencies. The platform serves a diverse clientele, including farmers, agronomists, researchers, food processors, and agricultural enterprises, facilitating real-time insights and predictive analytics that enhance productivity and sustainability. Established in 2014, Arable is headquartered in San Francisco, California, with an additional office in Princeton, New Jersey. The company has received various accolades, highlighting its innovation in agricultural technology.
Solsten
Series A in 2020
Solsten is an AI company based in Berlin, Germany, that specializes in understanding human behavior in the digital landscape to enhance customer experience. Founded in 2018 by Joe Schaeppi and Bastian Bergmann, the firm offers a customer engagement platform that assists decision-makers in the gaming industry, including executives, researchers, and marketing professionals from medium-to-large studios. Solsten's platform aims to improve user engagement by helping developers locate, retain, and monetize players effectively. It facilitates sustainable monetization strategies, aids in game development, and enables studios to reach untapped audiences, ultimately streamlining the development process and bringing products to market more efficiently.
Arable
Venture Round in 2020
Arable Labs, Inc. specializes in developing a solar-powered Internet of Things (IoT) device equipped with advanced sensors for in-field crop monitoring. This technology allows farmers to digitize and optimize their agricultural decisions by providing critical data about the impact of weather and other factors on crop yield, quality, and harvest timing. Arable's integrated system combines unique spectral and thermal sensors with agronomic modeling and software tools, enabling users to monitor crop development and identify stressors such as water or nutrient deficiencies. The platform serves a diverse clientele, including farmers, agronomists, researchers, food processors, and agricultural enterprises, facilitating real-time insights and predictive analytics that enhance productivity and sustainability. Established in 2014, Arable is headquartered in San Francisco, California, with an additional office in Princeton, New Jersey. The company has received various accolades, highlighting its innovation in agricultural technology.
Perennial
Venture Round in 2020
Cloud Agronomics Inc. is a geospatial imaging and analytics company that specializes in providing real-time analytics and predictive insights regarding crop performance to enhance agricultural practices. Founded in 2017 and headquartered in Lewes, Delaware, the company utilizes remote sensing technology to deliver actionable farm management insights. Its offerings include carbon monitoring, digital agronomy, and yield predictions, enabling farmers to identify and address crop disease outbreaks effectively. By providing these advanced analytical tools, Cloud Agronomics aims to optimize agricultural productivity and sustainability.
Conversa Health
Venture Round in 2020
Conversa Health, Inc. specializes in patient relationship management solutions aimed at enhancing communication between patients and healthcare teams. The company's flagship offering, the Conversa Virtual Care and Communication Platform, streamlines patient engagement and improves health outcomes through automated, personalized messaging based on comprehensive patient profiles derived from electronic health records, biometric devices, and self-reported data. This platform enables health systems, pharmaceutical companies, and payers to shift from reactive communication to proactive engagement, facilitating better management of chronic conditions, acute discharges, and preventive care. Conversa also provides Digital Checkups, which generate tailored clinical questions and alerts based on individual patient data, and Conversa Connect, a patient profiling and health signals engine. Established in 2013 and headquartered in Portland, Oregon, with additional offices in New York, North Carolina, and California, Conversa Health serves a diverse clientele, including healthcare providers, health systems, and health technology companies.
Conversa Health
Series B in 2020
Conversa Health, Inc. specializes in patient relationship management solutions aimed at enhancing communication between patients and healthcare teams. The company's flagship offering, the Conversa Virtual Care and Communication Platform, streamlines patient engagement and improves health outcomes through automated, personalized messaging based on comprehensive patient profiles derived from electronic health records, biometric devices, and self-reported data. This platform enables health systems, pharmaceutical companies, and payers to shift from reactive communication to proactive engagement, facilitating better management of chronic conditions, acute discharges, and preventive care. Conversa also provides Digital Checkups, which generate tailored clinical questions and alerts based on individual patient data, and Conversa Connect, a patient profiling and health signals engine. Established in 2013 and headquartered in Portland, Oregon, with additional offices in New York, North Carolina, and California, Conversa Health serves a diverse clientele, including healthcare providers, health systems, and health technology companies.
Betterview
Convertible Note in 2020
Betterview is a property intelligence platform tailored for property and casualty insurers, focusing on the analysis, scoring, management, and monitoring of property risk. By utilizing geospatial data and proprietary machine learning technology, Betterview transforms complex data into clear and actionable insights. This enables insurers to identify and mitigate risks effectively, enhancing operational efficiency and transparency throughout the policy lifecycle. The platform streamlines processes such as pricing, underwriting, and renewals, allowing insurers to make informed decisions and concentrate their efforts on high-risk properties, ultimately improving the overall customer experience.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.